Novel IL-6 Blocker Matches Humira in Rheumatoid Arthritis

(MedPage Today) -- A new type of anti-interleukin-6 (IL-6) biologic called olokizumab was as effective as adalimumab (Humira) in rheumatoid arthritis patients who needed a step up from methotrexate monotherapy, results from a phase III trial indicated...
Source: MedPage Today Rheumatology - Category: Rheumatology Source Type: news